Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Gattenlohner, S; Etschmann, B; Riedmiller, H; Muller-Hermelink, HK.
Lack of KRAS and BRAF mutation in renal cell carcinoma.
Eur Urol. 2009; 55(6):1490-1491 Doi: 10.1016/j.eururo.2009.02.024
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Gattenlöhner Stefan
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Find related publications in this database (using NLM MeSH Indexing)
Antibodies, Monoclonal - therapeutic use
Biopsy, Needle -
Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - genetics Carcinoma, Renal Cell - pathology
Cohort Studies -
DNA Mutational Analysis -
Female -
Follow-Up Studies -
Gene Expression Regulation, Neoplastic -
Genes, ras - drug effects Genes, ras - genetics
Humans -
Immunohistochemistry -
Kidney Neoplasms - drug therapy Kidney Neoplasms - genetics Kidney Neoplasms - pathology
Male -
Mutation -
Polymerase Chain Reaction -
Proto-Oncogene Proteins B-raf - drug effects Proto-Oncogene Proteins B-raf - genetics
Receptor, Epidermal Growth Factor - therapeutic use
Risk Assessment -
Sensitivity and Specificity -

© Med Uni GrazImprint